Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Stakeholder perspectives of care for people living with dementia moving from hospital to care facilities in the community: a systematic review.

Richardson A, Blenkinsopp A, Downs M, Lord K.

BMC Geriatr. 2019 Jul 31;19(1):202. doi: 10.1186/s12877-019-1220-1.

2.

Evaluating recruitment methods of patients with advanced cancer: a pragmatic opportunistic comparison.

Edwards Z, Bennett MI, Petty D, Blenkinsopp A.

Int J Pharm Pract. 2019 Dec;27(6):536-544. doi: 10.1111/ijpp.12562. Epub 2019 Jul 9.

PMID:
31287212
3.

A community pharmacist medicines optimisation service for patients with advanced cancer pain: a proof of concept study.

Edwards Z, Bennett MI, Blenkinsopp A.

Int J Clin Pharm. 2019 Jun;41(3):700-710. doi: 10.1007/s11096-019-00820-8. Epub 2019 Apr 9.

4.

Gaps, traps, bridges and props: a mixed-methods study of resilience in the medicines management system for patients with heart failure at hospital discharge.

Fylan B, Marques I, Ismail H, Breen L, Gardner P, Armitage G, Blenkinsopp A; ISCOMAT Programme Team.

BMJ Open. 2019 Feb 19;9(2):e023440. doi: 10.1136/bmjopen-2018-023440.

5.

Pharmacist joint-working with general practices: evaluating the Sheffield Primary Care Pharmacy Programme. A mixed-methods study.

Marques I, Gray NJ, Tsoneva J, Magirr P, Blenkinsopp A.

BJGP Open. 2018 Oct 17;2(4):bjgpopen18X101611. doi: 10.3399/bjgpopen18X101611. eCollection 2018 Dec.

6.

Pharmacist educational interventions for cancer pain management: a systematic review and meta-analysis.

Edwards Z, Ziegler L, Craigs C, Blenkinsopp A, Bennett MI.

Int J Pharm Pract. 2019 Aug;27(4):336-345. doi: 10.1111/ijpp.12516. Epub 2019 Feb 1. Review.

PMID:
30707465
7.

Cardiology patients' medicines management networks after hospital discharge: A mixed methods analysis of a complex adaptive system.

Fylan B, Tranmer M, Armitage G, Blenkinsopp A.

Res Social Adm Pharm. 2019 May;15(5):505-513. doi: 10.1016/j.sapharm.2018.06.016. Epub 2018 Jun 30.

PMID:
30001861
8.

How do patients with cancer pain view community pharmacy services? An interview study.

Edwards Z, Blenkinsopp A, Ziegler L, Bennett MI.

Health Soc Care Community. 2018 Jul;26(4):507-518. doi: 10.1111/hsc.12549. Epub 2018 Feb 26.

PMID:
29479766
9.

Self-management toolkit and delivery strategy for end-of-life pain: the mixed-methods feasibility study.

Bennett MI, Mulvey MR, Campling N, Latter S, Richardson A, Bekker H, Blenkinsopp A, Carder P, Closs J, Farrin A, Flemming K, Gallagher J, Meads D, Morley S, O'Dwyer J, Wright-Hughes A, Hartley S.

Health Technol Assess. 2017 Dec;21(76):1-292. doi: 10.3310/hta21760.

10.

A qualitative study of patient involvement in medicines management after hospital discharge: an under-recognised source of systems resilience.

Fylan B, Armitage G, Naylor D, Blenkinsopp A.

BMJ Qual Saf. 2018 Jul;27(7):539-546. doi: 10.1136/bmjqs-2017-006813. Epub 2017 Nov 16.

PMID:
29146681
11.

Characterising the growth in palliative care prescribing 2011-2015: Analysis of national medical and non-medical activity.

Ziegler L, Bennett MI, Mulvey M, Hamilton T, Blenkinsopp A.

Palliat Med. 2018 Apr;32(4):767-774. doi: 10.1177/0269216317739805. Epub 2017 Nov 13.

12.

Opioid prescribing for patients with cancer in the last year of life: a longitudinal population cohort study.

Ziegler L, Mulvey M, Blenkinsopp A, Petty D, Bennett MI.

Pain. 2016 Nov;157(11):2445-2451.

13.

Patients' knowledge of new medicines after discharge from hospital: What are the effects of hospital-based discharge counseling and community-based medicines use reviews (MURs)?

Elson R, Cook H, Blenkinsopp A.

Res Social Adm Pharm. 2017 May - Jun;13(3):628-633. doi: 10.1016/j.sapharm.2016.05.001. Epub 2016 May 13.

PMID:
27283244
14.

Community pharmacists' experience and perceptions of the New Medicines Service (NMS).

Lucas B, Blenkinsopp A.

Int J Pharm Pract. 2015 Dec;23(6):399-406. doi: 10.1111/ijpp.12180. Epub 2015 Feb 25.

PMID:
25712253
15.

Non-medical prescribing in palliative care: a regional survey.

Ziegler L, Bennett M, Blenkinsopp A, Coppock S.

Palliat Med. 2015 Feb;29(2):177-81. doi: 10.1177/0269216314557346. Epub 2014 Dec 12.

16.

An evaluation of an intervention designed to improve the evidence-based supply of non-prescription medicines from community pharmacies.

Ngwerume K, Watson M, Bond C, Blenkinsopp A.

Int J Pharm Pract. 2015 Apr;23(2):102-10. doi: 10.1111/ijpp.12118. Epub 2014 May 20.

PMID:
24841328
17.

Patients' valuation of the prescribing nurse in primary care: a discrete choice experiment.

Gerard K, Tinelli M, Latter S, Smith A, Blenkinsopp A.

Health Expect. 2015 Dec;18(6):2223-35. doi: 10.1111/hex.12193. Epub 2014 Apr 11.

18.

Safety and quality of nurse independent prescribing: a national study of experiences of education, continuing professional development clinical governance.

Smith A, Latter S, Blenkinsopp A.

J Adv Nurs. 2014 Nov;70(11):2506-17. doi: 10.1111/jan.12392. Epub 2014 Apr 4.

PMID:
24698501
19.

Custom and practice: a multi-center study of medicines reconciliation following admission in four acute hospitals in the UK.

Urban R, Armitage G, Morgan J, Marshall K, Blenkinsopp A, Scally A.

Res Social Adm Pharm. 2014 Mar-Apr;10(2):355-68. doi: 10.1016/j.sapharm.2013.06.009. Epub 2014 Feb 14.

PMID:
24529643
20.

Survey of patients' experiences and perceptions of care provided by nurse and pharmacist independent prescribers in primary care.

Tinelli M, Blenkinsopp A, Latter S, Smith A, Chapman SR.

Health Expect. 2015 Oct;18(5):1241-55. doi: 10.1111/hex.12099. Epub 2013 Jun 24.

21.

Using haloperidol as an antiemetic in palliative care: informing practice through evidence from cancer treatment and postoperative contexts.

McLean SL, Blenkinsopp A, Bennett MI.

J Pain Palliat Care Pharmacother. 2013 Jun;27(2):132-5. doi: 10.3109/15360288.2013.782937. Epub 2013 Apr 29. Review.

PMID:
23627663
22.

'Like doing a jigsaw with half the parts missing': community pharmacists and the management of cancer pain in the community.

Savage I, Blenkinsopp A, Closs SJ, Bennett MI.

Int J Pharm Pract. 2013 Jun;21(3):151-60. doi: 10.1111/j.2042-7174.2012.00245.x. Epub 2012 Oct 9.

PMID:
23418926
23.

Valuing the extended role of prescribing pharmacist in general practice: results from a discrete choice experiment.

Gerard K, Tinelli M, Latter S, Blenkinsopp A, Smith A.

Value Health. 2012 Jul-Aug;15(5):699-707. doi: 10.1016/j.jval.2012.02.006. Epub 2012 May 23.

24.

Medicines optimisation in primary care: can community pharmacies deliver?

De Simoni A, Mullis R, Clyne W, Blenkinsopp A.

Br J Gen Pract. 2012 Aug;62(601):398-9. doi: 10.3399/bjgp12X653444. No abstract available.

25.

Are nurse and pharmacist independent prescribers making clinically appropriate prescribing decisions? An analysis of consultations.

Latter S, Smith A, Blenkinsopp A, Nicholls P, Little P, Chapman S.

J Health Serv Res Policy. 2012 Jul;17(3):149-56. doi: 10.1258/jhsrp.2012.011090. Epub 2012 Jun 25.

PMID:
22734082
26.

Prescribing and partnership with patients.

Bond C, Blenkinsopp A, Raynor DK.

Br J Clin Pharmacol. 2012 Oct;74(4):581-8. doi: 10.1111/j.1365-2125.2012.04330.x. Review.

27.

Medication reviews.

Blenkinsopp A, Bond C, Raynor DK.

Br J Clin Pharmacol. 2012 Oct;74(4):573-80. doi: 10.1111/j.1365-2125.2012.04331.x. Review.

28.

Non-medical prescribing: current and future contribution of pharmacists and nurses.

Latter S, Blenkinsopp A.

Int J Pharm Pract. 2011 Dec;19(6):381-2. doi: 10.1111/j.2042-7174.2011.00183.x. No abstract available.

PMID:
22060232
29.

Educational interventions by pharmacists to patients with chronic pain: systematic review and meta-analysis.

Bennett MI, Bagnall AM, Raine G, Closs SJ, Blenkinsopp A, Dickman A, Ellershaw J.

Clin J Pain. 2011 Sep;27(7):623-30. doi: 10.1097/AJP.0b013e31821b6be4. Review.

PMID:
21610491
30.

Development, validation and application of a patient satisfaction scale for a community pharmacy medicines-management service.

Tinelli M, Blenkinsopp A, Bond C.

Int J Pharm Pract. 2011 Jun;19(3):144-55. doi: 10.1111/j.2042-7174.2011.00110.x.

PMID:
21554439
31.

The feasibility of providing community pharmacy-based services for alcohol misuse: a literature review.

Watson MC, Blenkinsopp A.

Int J Pharm Pract. 2009 Aug;17(4):199-205. Review.

PMID:
20217944
32.

Evaluation of a cardiovascular disease opportunistic risk assessment pilot ('Heart MOT' service) in community pharmacies.

Horgan JM, Blenkinsopp A, McManus RJ.

J Public Health (Oxf). 2010 Mar;32(1):110-6. doi: 10.1093/pubmed/fdp092. Epub 2009 Oct 28.

PMID:
19864496
33.

Patients' experiences of a community pharmacy-led medicines management service.

Bissell P, Blenkinsopp A, Short D, Mason L.

Health Soc Care Community. 2008 Jul;16(4):363-9. doi: 10.1111/j.1365-2524.2007.00749.x.

PMID:
18613912
34.

Patient evaluation of a community pharmacy medications management service.

Tinelli M, Bond C, Blenkinsopp A, Jaffray M, Watson M, Hannaford P; Community Pharmacy Medicines Management Evaluation Team.

Ann Pharmacother. 2007 Dec;41(12):1962-70. Epub 2007 Oct 30.

PMID:
17971403
35.

The role and value of written information for patients about individual medicines: a systematic review.

Grime J, Blenkinsopp A, Raynor DK, Pollock K, Knapp P.

Health Expect. 2007 Sep;10(3):286-98. Review.

36.

A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines.

Raynor DK, Blenkinsopp A, Knapp P, Grime J, Nicolson DJ, Pollock K, Dorer G, Gilbody S, Dickinson D, Maule AJ, Spoor P.

Health Technol Assess. 2007 Feb;11(5):iii, 1-160. Review.

37.

Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.

Blenkinsopp A, Wilkie P, Wang M, Routledge PA.

Br J Clin Pharmacol. 2007 Feb;63(2):148-56. Review.

38.

Effectiveness of community physiotherapy and enhanced pharmacy review for knee pain in people aged over 55 presenting to primary care: pragmatic randomised trial.

Hay EM, Foster NE, Thomas E, Peat G, Phelan M, Yates HE, Blenkinsopp A, Sim J.

BMJ. 2006 Nov 11;333(7576):995. Epub 2006 Oct 20.

39.

Community pharmacy supply of emergency hormonal contraception: a structured literature review of international evidence.

Anderson C, Blenkinsopp A.

Hum Reprod. 2006 Jan;21(1):272-84. Epub 2005 Sep 2. Review.

PMID:
16143639
40.

Prospective study of the incidence, nature and causes of dispensing errors in community pharmacies.

Ashcroft DM, Quinlan P, Blenkinsopp A.

Pharmacoepidemiol Drug Saf. 2005 May;14(5):327-32.

PMID:
15386722
42.
43.

Prescribing by allied health professionals: the present position.

Blenkinsopp A, Reid S, Blenkinsopp J, Paxton P.

Musculoskeletal Care. 2003 Mar;1(1):71-6. doi: 10.1002/msc.41. No abstract available.

PMID:
20217666
44.

Proton pump inhibitors: perspectives of patients and their GPs.

Grime J, Pollock K, Blenkinsopp A.

Br J Gen Pract. 2001 Sep;51(470):703-11.

45.

Partnership with patients. Health professionals need to identify how much information patients want.

Blenkinsopp A, Bashford J, Dickinson D.

BMJ. 1998 Aug 8;317(7155):413-4. No abstract available.

46.

The rise and rise of proton pump inhibitor drugs: patients' perspectives.

Boath EH, Blenkinsopp A.

Soc Sci Med. 1997 Nov;45(10):1571-9.

PMID:
9351147
47.

Primary care--opportunities and threats. Developing prescribing in primary care.

Bradley CP, Taylor RJ, Blenkinsopp A.

BMJ. 1997 Mar 8;314(7082):744-7.

48.

Over the counter drugs. The future for self medication.

Bradley C, Blenkinsopp A.

BMJ. 1996 Mar 30;312(7034):835-7.

49.

Patients, society, and the increase in self medication.

Blenkinsopp A, Bradley C.

BMJ. 1996 Mar 9;312(7031):629-32.

50.

Effects of computer generated reminder charts on patients' compliance with drug regimens.

Raynor DK, Booth TG, Blenkinsopp A.

BMJ. 1993 May 1;306(6886):1158-61.

Supplemental Content

Loading ...
Support Center